deltorphin and Hypoglycemia

deltorphin has been researched along with Hypoglycemia* in 2 studies

Other Studies

2 other study(ies) available for deltorphin and Hypoglycemia

ArticleYear
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man.
    The Journal of clinical endocrinology and metabolism, 1992, Volume: 75, Issue:2

    To determine the role of delta-opioid receptors in the modulation of hypothalamic-pituitary-adrenal activity, we studied in normal subjects the effect of the highly selective delta-opioid receptor agonist deltorphin (DT) on the secretion of ACTH, cortisol, and arginine vasopressin in response to insulin-induced hypoglycemia. In an attempt to clarify the site of opiate modulation of ACTH secretion, we also studied in normal subjects the effect of DT on the ACTH response to ovine CRH-41. DT blunted the ACTH, cortisol, and arginine vasopressin responses to insulin-induced hypoglycemia, whereas it had no effect on the ACTH and cortisol responses to CRH. We conclude that DT-induced activation of delta-opioid receptors exerts an inhibitory influence on hypoglycemia-stimulated ACTH secretion. Based on the lack of an effect of DT on the ACTH response to CRH, we postulate that DT may modulate the secretion of ACTH through suprapituitary mechanisms.

    Topics: Adrenocorticotropic Hormone; Adult; Animals; Arginine Vasopressin; Blood Glucose; Corticotropin-Releasing Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Male; Oligopeptides; Pituitary-Adrenal System; Reference Values; Sheep

1992
delta-Opioid receptors and the secretion of growth hormone in man: effect of opioid delta-receptor agonist deltorphin on GH responses to GH-releasing hormone and insulin-induced hypoglycemia.
    Neuroendocrinology, 1992, Volume: 56, Issue:6

    To investigate the role of delta-opioid receptors in the modulation of growth hormone (GH) secretion, we compared in normal subjects the effect of the highly selective delta-opioid receptor agonist Deltorphin (DT) on the GH secretion responses to pituitary (GH-releasing hormone, GHRH)- and hypothalamic (insulin-induced hypoglycemia, IIH)-mediated stimuli. DT blunted the GH response to IIH, whereas it had no effect on the GH response to GHRH. It is concluded that in man DT-induced activation of delta-opioid receptors exerts an inhibitory action on hypoglycemia-stimulated GH secretion. Based on the lack of an effect of DT on the GH response to GHRH, we suggest that DT may modulate the secretion of GH through suprapituitary mechanisms.

    Topics: Adult; Blood Glucose; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Insulin; Male; Oligopeptides; Receptors, Opioid, delta; Time Factors

1992